Regeno blend (BPC-157 / TB-500 / Cartalax)_Dosage, benefits & legal status
Also known as Regeno, BPC-157 + TB-500 + Cartalax, Cartalax + BPC-157 + TB-500, TB-500 + BPC-157 + Cartalax, Cartalax blend
The Wolverine blend with a cartilage bioregulator added.
Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.
What is Regeno blend (BPC-157 / TB-500 / Cartalax)?
Plain language first. The technical label stays, but it never stands alone.Overview
It is the usual two healing peptides with a third one aimed at cartilage.
Regeno is a three-peptide vial combining BPC-157, TB-500 and Cartalax, the Khavinson tripeptide AED, typically at 10 mg of each in a 30 mg vial.
What it's used for
A named healing blend sold for joints and connective tissue, adding Cartalax to the standard BPC-157 and TB-500 pairing.
How does Regeno blend (BPC-157 / TB-500 / Cartalax) work?
What it does in the body, and where.Two of the three components are the standard healing pair. The third is what the name is selling.
- 01BPC-157 and TB-500 are the familiar combinationOne is associated with new blood vessel growth, the other with cell migration. That pairing is sold as Wolverine on its own.
- 02Cartalax is a Khavinson bioregulatorA three-residue peptide, Ala-Glu-Asp, from the St Petersburg bioregulator program, directed at cartilage and connective tissue.
- 03The pitch is a joint-directed version of WolverineThat is a reasonable idea, and it is the reason the blend exists commercially.
- 04No study has tested the three togetherThe same is true of every healing blend on this site. Each component's own evidence is on its own page, and none of it transfers to the mixture.
Where this compound is thought to act.
What else is it used for?
Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.
- Tendon, ligament and joint recovery, as soldResearch only
- Cartilage support, which is the reason Cartalax is in itResearch only
- General healing and recoveryResearch only
The published record
0
Papers and trials about Regeno blend (BPC-157 / TB-500 / Cartalax)
Europe PMC was searched on 12 October 2026 and returned nothing.
Counted from Europe PMC indexing, not read by a person.
At a glance
Four things to know about Regeno blend (BPC-157 / TB-500 / Cartalax)
Evidence
Category
Healing and recovery
Common vial
Varies
Half-life
Not meaningful for a blend
How much, and do you cycle it?
The range, and whether you take breaks.0.25 up to 0.5 mg BPC-157 per day (the rest follows your ratio), varies. No established schedule No range
No study has established a duration or a break for this combination. Community courses run four to eight weeks, borrowed from BPC-157 and TB-500 practice.
Not meaningful for a blendNo figure
Each component clears on its own schedule, so a single figure would be misleading. Check each component's page.
You can compare this against the whole library to see where it sits.
How do I dose and price it?
Enter your vial and your dose. Pick a mix. We show the draw and the cost.The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.
The configuration sold is an even 10 mg of each in a 30 mg vial, which makes it simpler than Coremend, where TB-500 sits at two and a half times the others. Regeno is one vendor's product name. Other sellers offer the same three peptides under their own names, and at least one adds KPV as a fourth, so read your own label rather than assuming this ratio.
Pick your vial to see concentrations and a draw.
Choose your mix
Measuring the water1 mL = one full 100-unit syringe.
Your draw
What one draw delivers
The same arithmetic as the calculator, worked out for the vials vendors sell.Dose anchored to BPC-157, at the 0.25 to 0.5 mg per day people commonly cite. Each table assumes one draw per day. If you split it across more injections, divide the reading by the number of injections.
| BPC-157 dose | 1 mL water | 2 mL water | 3 mL water |
|---|---|---|---|
| 0.25 mg | 2.5 units
| 5.0 units
| 7.5 units
|
| 0.5 mg | 5.0 units
| 10.0 units
| 15.0 units
|
No published human study establishes a dose for this blend. The range comes from vendor and community practice and is anchored to one component, because a blend is one draw.
On the even 10/10/10 vial, a draw giving 500 mcg of BPC-157 gives 500 mcg each of TB-500 and Cartalax alongside it. Daily dosing at that rate puts TB-500 near 3.5 mg per week, inside its own commonly cited 2 to 5 mg weekly range, though spread across seven small doses where it is usually given two or three times a week. The even ratio is what makes this blend easier to reason about than Coremend.
Regeno blend (BPC-157 / TB-500 / Cartalax) starts at $159.00 across 2 vendors.
2 listings, last read Oct 10, 2026. Shipping and card fees are not included.
How do you store it?
Before mixing, and after.Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.
Unmixed lyophilized Regeno blend (BPC-157 / TB-500 / Cartalax) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.
What are the side effects and cautions?
Known cautions and warnings for this compound.Who should avoid it
- Any active cancer, since all three components affect tissue growth or repair signaling
- Pregnancy and breastfeeding
- Any undiagnosed lump, swelling or joint change
- Banned in drug-tested sport
Stop and get help
- Spreading redness, heat or swelling at an injection site
- New lumps or masses
- Joint pain that worsens rather than settles
- Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing
Common effects
- Injection site redness or soreness
- Fatigue in the first few days, reported anecdotally
- Nothing systematic, since the blend has not been studied
Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.
Is Regeno blend (BPC-157 / TB-500 / Cartalax) approved?
And where the numbers on this page come from.No. Regeno blend (BPC-157 / TB-500 / Cartalax) is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.
- Approval statusResearch only
- RouteUnder the skin (subcutaneous)
- Checked24 August 2026
- DoseFrom community reports. No regulator or trial established this dose.
- Vial sizeFrom what vendors typically list; not a recommendation.
- Sources
What has happened recently
Not approved anywhere, and neither is any of its three components. Regeno is a trade name rather than a defined product: the same three peptides are sold by other vendors under their own blend names, and at least one seller offers a four-way version that adds KPV. Cartalax is the least established of the three, with its sequence documented in supplier certificates rather than a primary chemical database. BPC-157 and TB-500 are both prohibited in sport at all times by WADA.
Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.
You can compare this against the whole library, or read how to check a seller.
What else is like Regeno blend (BPC-157 / TB-500 / Cartalax)?
Others in Healing and recovery, side by side.If you're weighing Regeno blend (BPC-157 / TB-500 / Cartalax), it's worth reading Ac-SDKP (TB-500 Fragment 1-4), Larazotide, and Teriparatide (Forteo) in the same class.
The Wolverine blend with a cartilage bioregulator added.
- Dose
- 0.25 up to 0.5 mg BPC-157 per day (the rest follows your ratio)
- How often
- Varies
The first four amino acids of TB-500, and a drug candidate in its own right.
- Dose
- No established human dose
- How often
- No established schedule
An oral peptide studied for sealing a leaky gut, mainly in celiac disease.
- Dose
- 0.5 mg per dose
- How often
- Before meals
The bone drug that builds new bone instead of just slowing the loss.
- Dose
- 20 mcg per day
- How often
- Daily
Guides for this compound
- How to Reconstitute a Peptide
Mix peptide powder with bacteriostatic water, step by step.
- How to Read an Insulin Syringe
Read the units, convert to millilitres, and draw the exact dose.
- mcg vs mg: The Peptide Dosing Mistake to Avoid
Your vial says mg and your protocol says mcg. Here is the conversion and how to check it.
- How to Read a Peptide COA
What the purity number does and does not tell you, and how to spot an edited report.
- How to Vet a Peptide Vendor
Independent COAs, HPLC purity, and the red flags that mean walk away.
Sources
- Khavinson peptide bioregulators, review of the short-peptide programme(2020)Background on the short-peptide bioregulator family that Cartalax belongs to.
- Sikiric et al., BPC-157 review of tendon and ligament healing work(2018)Animal evidence for the BPC-157 component. No human trial of any blend containing it exists.